Analysts Teleconference | Pfizer Limited

Contact Us

Investors

Careers

Science

Contact Us

Investor Relations

ANALYSTS TELECONFERENCE

2020-2021

2016-2017

4th Quarter

Pfizer Limited – Details of Analysts Teleconference May 18, 2017

Pfizer Limited – Analysts Teleconference Transcript – May 18, 2017

2015-2016

2014-2015

Audited Results – Year ended March 31, 2015

2013-2014

Pfizer-Wyeth Merger

Presentation – Proposed Merger of Wyeth Ltd with Pfizer Ltd

Audited Results- Year Ended March 31, 2014

2012-2013

Audited Results – Year Ended March 31, 2013

2011-2012

Audited Results – Year Ended March 31, 2012

Company Details

Board of Directors

Capital History

Financial Information

Financial Information

Policies & Procedures

Model Code of Conduct

Code for Independent Directors

Terms and Conditions of Appointment of Independent Directors

Whistle Blower/Vigil Mechanismwhistle-blower-vigil-mechanism

Policy on Related Party Transactions

Policy on Corporate Social Responsibility

Code for Fair Disclosure

Familiarization Program for Independent - Directors

Policy on criteria for determining materiality of - events

Archival policy for website content

Dividend Distribution Policy

The Blue Book – Summary of Pfizer Polices on - Business Conduct

Analysts Teleconference

Analysts Teleconference

Investor Services

Frequently Asked Questions

Listing & Other Information

Unclaimed Dividend & Shares

Grievance Redressal

Statutory Communications

Compliances under Listing Regulations 2015

Corporate Governance Report

Shareholding Pattern

Newspaper Advertisements

About Us Our People Our Community Efforts Our Products

Investors Career Media Adverse Event Reporting Health Care Professionals

Terms of Use Privacy Policy Contact Us

Copyright © 2002- 2021 Pfizer Inc. All rights reserved.